ASCO 2021 Leukemia - Physician's Weekly


ASCO 2021 Leukemia

First Head-to-Head Results: Acalabrutinib vs Ibrutinib in CLL

Final results from the head-to-head ELEVATE-RR Phase III trial of acalabrutinib demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in...

Herpes Zoster In CLL: Effect Of Vaccination And Treatment

Herpes zoster (HZ) is prevalent in patients with Chronic Lymphocytic Leukemia (CLL) and affects younger patients who require chemotherapy. The risk of developing HZ increases in recipients of first and second line chemotherapy....

Survival Trends In CLL In the Era Of Oral Targeted Therapies

Survival is significantly improved by calendar period among patients diagnosed after 2004 and treated in the era of advanced therapies. Females and younger patients had a higher probability of long term survival. The survival of...

Exercise And Quality Diet After Leukemia

A 24-month phone and app/web-based diet and physical activity intervention that was successful for weight loss in the general population did not result in greater weight loss or improvement in cardiovascular (CV) risk factors...

Palliative Care And Coping In Patients With AML

Palliative care and coping in patients with acute myeloid leukemia receiving intensive induction therapy: A mediation analysis of data from a randomized trial.   Integrated palliative and oncology care (IPC) as part of...



For latest news and updates
Email-id is invalid